期刊文献+

同型半胱氨酸与慢性肾脏疾病

下载PDF
导出
作者 张贺平
出处 《哈尔滨医药》 2009年第4期68-69,共2页 Harbin Medical Journal
  • 相关文献

参考文献16

  • 1Suliman ME, Stenvinkel P, Barany P, et al Hyperhomocy - steinemia, malnutrition, and inflammalion in ESRD patients [J]. Semin Nephrol,2006,26 : 14 - 19.
  • 2Garibotto G, Sofia A, Valli A, et al. Causes of Hyperhomocysteinemia in patients with chronic kidney diseases [ J ]. Semin Nephrol, 2006,26 ( 3 ) : 1 - 7.
  • 3Oley RN, Parfrey PS. Clinical epidemiology of cardiovascular diease in chronic renal disease[J]. Am J Kidney Dis, 1998,32 ( Suppl 3) :112 -119.
  • 4Alessandra F, Perna DI. Possible mechanisms of homocysteine toxicity[ J ]. Kid lnt ,2003,63 ( Suppl 84 ) : 137 - 140.
  • 5路建饶,武立群,顾波,王汉清,邹盛淮,倪玉美.老年慢性肾衰血液透析患者血浆同型半胱氨酸的临床研究[J].中国老年学杂志,2005,25(5):519-521. 被引量:4
  • 6Jakubowski H. Aminoacyl thioester chemistry of class II aminoacyl - Trna synthetases [ J ]. Biochemistry, 1997,36 ( 37 ) : 11077 - 11085.
  • 7Perna AF, De Santo NG. lngrosso D Adverse effects of hyperhomocy steinemia and their managerment by folic acid [ J ]. Miner Electrol Mctab, 1997,23 : 174 - 178.
  • 8何俊,丁敏,张晓清,袁泰先.高效液相色谱法同时测定血浆同型半胱氨酸及其相关硫醇物浓度方法的建立[J].中华检验医学杂志,2006,29(3):203-206. 被引量:17
  • 9Peter WF,Homocysteine an dcoronary heart disease how great is the hazard [ J ]. JAMA,2002,288:2042 - 2043.
  • 10王清涛,秦晓光.同型半胱氨酸的检测和临床应用[J].中华检验医学杂志,2006,29(3):193-195. 被引量:82

二级参考文献43

  • 1[1]Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem,1994;40:873~881
  • 2[2]Jacobsen DW. Cardiovascular disorders(risk assessment). Clin Chem, 1993; 65: 367R~373R
  • 3[3]Yeun JY. The role of homocysyeine in end - stage renal disease.Seminars in Dialysis,1998;11 (2):95~101
  • 4[4]Nygard O, Norderhaug JE, Refsum H, et aL Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med, 1997; 337: 230~236
  • 5[5]Bostom AG, Lathrop L.Hyperhomocyststeinemia in end - stage renal disease: Prevalence, etiology, and potential relationship to artherosclerotic outcomes. Kidney Int, 1997 ; 52:10~20
  • 6[6]Foley RN,Parfrey PS, Sarnak MJ,Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998;32[Suppl3]:112~119
  • 7[7]Yu HH,Joubran R,Asmi M, et al. Agreement among four homocysteine assays and results in patients with coronary atherosclerofis and controls.Clin Chem, 2000;46(2): 258~264.
  • 8[8]Robinson K, Gupta A, Dennis VM, et al. Hyperhomocysteinemia confers an independent increased risk of athernsclerosis in end stage renal diseas and is closely linked to plasma folate and pyridoxine concentrations. Circulation, 1996; 94 : 2743~2748
  • 9[9]Hultberg B, Andersson A, Arnadottir M. Reduced, free and total fractions of homocysteine and other thiol compounds in plasma from patients with renal failure. Nephron, 1995; 70: 62~67
  • 10[11]Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum: methods and applications. Clin Chem, 1993;39:1764 ~1773

共引文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部